Timing of onset of garadacimab for preventing hereditary angioedema attacks
Loading...
Date issued
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Reuse License
Abstract
- Garadacimab provided consistent HAE attack prevention in manufacturer-funded post hoc pivotal Phase 3 data analysis.
- Protection from HAE attacks occurred by Week 1 after first administration.
Description
Keywords
Citation
Published in
Clinical & experimental allergy, 54, 12, Blackwell Science, Oxford, 2024, https://doi.org/10.1111/cea.14568